← Back to Search

Screening Tools for Colorectal Cancer

N/A

Waitlist Available

Led By Celette Skinner, PhD

Research Sponsored by University of Texas Southwestern Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Male or female patients, ages 25-64, presenting for appointment will be eligible to participate

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up three years

Awards & highlights

Study Summary

This trial is looking at how to best screen for colon cancer in a group of under- and uninsured patients in Dallas, in order to find the most effective and efficient way to do this.

Who is the study for?

This trial is for men and women aged 25-64 who are visiting the clinic. Those aged 25-49 must have a family history of colorectal cancer or their own history of bowel disease or polyps. All racial and ethnic groups, as well as English and Spanish speakers, can join. People with personal colorectal cancer history, severe hearing/speech impairments, or without informed consent cannot participate.Check my eligibility

What is being tested?

The PROSPR project aims to find the best ways to screen for colon cancer in a diverse group using safety-net clinics. It will test tools like step completion assessments and computerized risk stratification algorithms to personalize screening methods based on individual risks.See study design

What are the potential side effects?

Since this study focuses on screening optimization rather than medication or invasive procedures, traditional side effects are not applicable here. However, there may be indirect consequences related to privacy concerns or anxiety from personalized risk assessments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 25 and 64 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ three years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~three years

This trial's timeline: 3 weeks for screening, Varies for treatment, and three years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of patients achieving appropriate screening regimen.

Trial Design

1Treatment groups

Experimental Treatment

Group I: ScreeningExperimental Treatment3 Interventions

Employ innovative methods for assessing personalized guideline-based screening in the clinic setting to evaluate guideline-based, over- and under-screening. Interventions include Computerized Risk Stratification Tool, Algorithmic Risk Stratification Tool, and Step completion assessment.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor

1,047 Previous Clinical Trials

1,043,934 Total Patients Enrolled

Celette Skinner, PhDPrincipal InvestigatorUT Southwestern Medical Center

Media Library

Screening Clinical Trial Eligibility Overview. Trial Name: NCT03705897 — N/A

Colorectal Cancer Research Study Groups: Screening

Colorectal Cancer Clinical Trial 2023: Screening Highlights & Side Effects. Trial Name: NCT03705897 — N/A

Screening 2023 Treatment Timeline for Medical Study. Trial Name: NCT03705897 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings for participants in this research trial?

"As per the data hosted on clinicaltrials.gov, this trial is not actively seeking participants at present. The experimental protocol was initially released in August 2013 and last revised back in September 2022; however, there are currently 861 other trials recruiting patients."

Answered by AI

Does this research endeavor include participants aged twenty or over?

"Those hoping to be included in this trial must meet the age restriction of 25-64. Alternatively, there are 30 trials available for patients below 18 and 848 studies that cater to those over 65 years old."

Answered by AI

To what extent can individuals partake in this research?

"This clinical trial is looking to recruit 9865 individuals between the ages of 25 and 64 who have been diagnosed with colorectal cancer. Eligible patients must also meet additional conditions, such as having a family history of colorectal cancer or personal history of inflammatory bowel disease/adenomatous polyps (for those aged 25-49). There are no restrictions on racial or ethnic groupings, thus allowing male and female patients from all backgrounds to participate."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

PROSPR Project 1: Identifying and Tracking Personalized CRC Screening Regimens for Patients in Clinical Settings

Celette Skinner 2013. "PROSPR Project 1: Identifying and Tracking Personalized CRC Screening Regimens for Patients in Clinical Settings". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03705897.